Anbio Biotechnology Class A Financial Overview
Anbio Biotechnology Class A's market cap is currently $4.16B. The company's EPS TTM is $0.06; its P/E ratio is 476.90; Anbio Biotechnology Class A is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.